Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma Journal Article

  

Authors:	Modak, S.; Cheung, N. K. V.; Abramson, S. J.; Price, A. P.
Article Title:	Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma
Keywords:	adolescent; child; preschool child; child, preschool; unclassified drug; clinical feature; clinical trial; bevacizumab; drug withdrawal; side effect; note; bone metastasis; antineoplastic agent; letter; colorectal cancer; metastasis; multiple cycle treatment; monoclonal antibody; drug dose escalation; antibodies, monoclonal; neuroblastoma; chemically induced disorder; radiography; hemangiomatosis; maximum tolerated dose; phase 1 clinical trial; femur; radiodiagnosis; monoclonal antibody 3f8 i 131; tibia; bone disease; bone defect; bone dysplasia; bone radiography; epiphysis; growth plate; knee radiography; metaphysis; x ray; bone diseases
Journal Title:	Pediatric Blood and Cancer
Volume:	52
Issue:	2
ISSN:	1545-5009
Publisher:	Wiley Periodicals, Inc
Date Published:	2009-02-01
Start Page:	304
End Page:	305
Language:	English
DOI:	10.1002/pbc.21776
PUBMED:	18819126
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-59449086433&partnerID=40&md5=5b4c551667da48bef6f728b732892f36
Notes:	--- - "Export Date: 30 November 2010" - "CODEN: PBCEA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/1047